• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

甲状腺间变性癌的基因组和进化景观。

The genomic and evolutionary landscapes of anaplastic thyroid carcinoma.

机构信息

Department of Otolaryngology - Head and Neck Surgery, Western University, London, ON, Canada; London Regional Cancer Program, London, ON, Canada; Lawson Health Research Institute, London, ON, Canada; Department of Oncology, Western University, London, ON, Canada.

Ontario Institute for Cancer Research, Toronto, ON, Canada; Institute for Precision Health, University of California, Los Angeles, Los Angeles, CA, USA; Jonsson Comprehensive Cancer Center, University of California, Los Angeles, Los Angeles, CA, USA.

出版信息

Cell Rep. 2024 Mar 26;43(3):113826. doi: 10.1016/j.celrep.2024.113826. Epub 2024 Feb 26.

DOI:10.1016/j.celrep.2024.113826
PMID:38412093
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11077417/
Abstract

Anaplastic thyroid carcinoma is arguably the most lethal human malignancy. It often co-occurs with differentiated thyroid cancers, yet the molecular origins of its aggressivity are unknown. We sequenced tumor DNA from 329 regions of thyroid cancer, including 213 from patients with primary anaplastic thyroid carcinomas. We also whole genome sequenced 9 patients using multi-region sequencing of both differentiated and anaplastic thyroid cancer components. Using these data, we demonstrate thatanaplastic thyroid carcinomas have a higher burden of mutations than other thyroid cancers, with distinct mutational signatures and molecular subtypes. Further, different cancer driver genes are mutated in anaplastic and differentiated thyroid carcinomas, even those arising in a single patient. Finally, we unambiguously demonstrate that anaplastic thyroid carcinomas share a genomic origin with co-occurring differentiated carcinomas and emerge from a common malignant field through acquisition of characteristic clonal driver mutations.

摘要

间变性甲状腺癌可以说是最致命的人类恶性肿瘤。它常与分化型甲状腺癌同时发生,但目前尚不清楚其侵袭性的分子起源。我们对包括 213 例原发性间变性甲状腺癌患者在内的 329 个甲状腺癌区域的肿瘤 DNA 进行了测序。我们还对 9 名患者使用分化型和间变性甲状腺癌成分的多区域测序进行了全基因组测序。利用这些数据,我们证明间变性甲状腺癌的突变负担高于其他甲状腺癌,具有不同的突变特征和分子亚型。此外,不同的癌症驱动基因在间变性和分化型甲状腺癌中发生突变,即使它们发生在单个患者中。最后,我们明确证明间变性甲状腺癌与同时发生的分化型癌具有共同的基因组起源,并通过获得特征性克隆驱动突变从共同的恶性区域中出现。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1220/11077417/5af0c2b43e9f/nihms-1980905-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1220/11077417/0694d5fe150b/nihms-1980905-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1220/11077417/4bef2da6d923/nihms-1980905-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1220/11077417/830af5ca6749/nihms-1980905-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1220/11077417/92506ff9c88b/nihms-1980905-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1220/11077417/5af0c2b43e9f/nihms-1980905-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1220/11077417/0694d5fe150b/nihms-1980905-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1220/11077417/4bef2da6d923/nihms-1980905-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1220/11077417/830af5ca6749/nihms-1980905-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1220/11077417/92506ff9c88b/nihms-1980905-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1220/11077417/5af0c2b43e9f/nihms-1980905-f0005.jpg

相似文献

1
The genomic and evolutionary landscapes of anaplastic thyroid carcinoma.甲状腺间变性癌的基因组和进化景观。
Cell Rep. 2024 Mar 26;43(3):113826. doi: 10.1016/j.celrep.2024.113826. Epub 2024 Feb 26.
2
Molecular Pathology of Poorly Differentiated and Anaplastic Thyroid Cancer: What Do Pathologists Need to Know?低分化和间变性甲状腺癌的分子病理学:病理学家需要了解什么?
Endocr Pathol. 2021 Mar;32(1):63-76. doi: 10.1007/s12022-021-09665-2. Epub 2021 Feb 4.
3
Clonal evolution analysis of paired anaplastic and well-differentiated thyroid carcinomas reveals shared common ancestor.对配对的间变性和高分化甲状腺癌的克隆进化分析显示存在共同的祖先。
Genes Chromosomes Cancer. 2018 Dec;57(12):645-652. doi: 10.1002/gcc.22678. Epub 2018 Sep 24.
4
Genomic Landscape of poorly Differentiated and Anaplastic Thyroid Carcinoma.低分化和间变性甲状腺癌的基因组图谱
Endocr Pathol. 2016 Sep;27(3):205-12. doi: 10.1007/s12022-016-9445-4.
5
Whole-genome sequencing of synchronous thyroid carcinomas identifies aberrant DNA repair in thyroid cancer dedifferentiation.同步甲状腺癌的全基因组测序鉴定出甲状腺癌去分化中的异常 DNA 修复。
J Pathol. 2020 Feb;250(2):183-194. doi: 10.1002/path.5359. Epub 2019 Nov 29.
6
Prevalence of a hobnail pattern in papillary, poorly differentiated, and anaplastic thyroid carcinoma: a possible manifestation of high-grade transformation.乳头状、低分化和间变性甲状腺癌中出现钉突样模式的流行:高级别转化的一种可能表现。
Am J Surg Pathol. 2015 Feb;39(2):260-5. doi: 10.1097/PAS.0000000000000329.
7
Genomic and transcriptomic hallmarks of poorly differentiated and anaplastic thyroid cancers.低分化和间变性甲状腺癌的基因组和转录组特征
J Clin Invest. 2016 Mar 1;126(3):1052-66. doi: 10.1172/JCI85271. Epub 2016 Feb 15.
8
Genomic Alterations in Fatal Forms of Non-Anaplastic Thyroid Cancer: Identification of and as Novel Thyroid Cancer Genes Associated with Tumor Virulence.非未分化型甲状腺癌致死形式中的基因组改变:鉴定 和 为与肿瘤毒力相关的新型甲状腺癌基因。
Clin Cancer Res. 2017 Oct 1;23(19):5970-5980. doi: 10.1158/1078-0432.CCR-17-1183. Epub 2017 Jun 20.
9
Anaplastic Thyroid Carcinoma: Current Issues in Genomics and Therapeutics.间变性甲状腺癌:基因组学与治疗学的当前问题。
Curr Oncol Rep. 2021 Feb 13;23(3):31. doi: 10.1007/s11912-021-01019-9.
10
The genomic and transcriptomic landscape of anaplastic thyroid cancer: implications for therapy.间变性甲状腺癌的基因组和转录组图谱:对治疗的启示
BMC Cancer. 2015 Dec 18;15:984. doi: 10.1186/s12885-015-1955-9.

引用本文的文献

1
Diagnostic Evaluation of Anaplastic Thyroid Carcinoma in Core Biopsy Specimens: Morphologic, Immunohistochemical, Molecular, and Therapeutic Considerations.粗针活检标本中未分化甲状腺癌的诊断评估:形态学、免疫组织化学、分子及治疗方面的考量
Endocr Pathol. 2025 Sep 4;36(1):32. doi: 10.1007/s12022-025-09876-x.
2
Progression of Follicular Thyroid Carcinomas to Anaplastic Thyroid Carcinomas: Molecular and Clinicopathologic Characteristics with Comparison to Papillary Thyroid Carcinoma-Derived Anaplastic Thyroid Carcinomas.滤泡性甲状腺癌向未分化甲状腺癌的进展:分子和临床病理特征,并与乳头状甲状腺癌衍生的未分化甲状腺癌进行比较
Endocr Pathol. 2025 Sep 1;36(1):30. doi: 10.1007/s12022-025-09875-y.
3

本文引用的文献

1
Anaplastic transformation in thyroid cancer revealed by single-cell transcriptomics.单细胞转录组学揭示甲状腺癌中的间变转化。
J Clin Invest. 2023 Jun 1;133(11):e169653. doi: 10.1172/JCI169653.
2
Analyzing TCGA Data to Identify Gene Mutations Linked to Hepatocellular Carcinoma in Asians.分析癌症基因组图谱(TCGA)数据以鉴定与亚洲人肝细胞癌相关的基因突变。
Gastrointest Tumors. 2022 Apr 20;9(2-4):43-58. doi: 10.1159/000524576. eCollection 2022 Dec.
3
Immune-based classification of HPV-associated oropharyngeal cancer with implications for biomarker-driven treatment de-intensification.
Remarkable Response to Chemo-immunotherapy In Anaplastic Thyroid Cancer.
化疗免疫疗法对间变性甲状腺癌有显著疗效。
JCEM Case Rep. 2025 Jul 28;3(9):luaf160. doi: 10.1210/jcemcr/luaf160. eCollection 2025 Sep.
4
Involvement of KEAP1/NRF2 pathway in non-BRAF mutated squamous cell carcinoma of the thyroid.KEAP1/NRF2通路在非BRAF突变型甲状腺鳞状细胞癌中的作用
J Pathol. 2025 Aug;266(4-5):481-494. doi: 10.1002/path.6444. Epub 2025 Jul 2.
5
Real-world treatment outcomes and clinicopathologic and molecular determinants of response to first-line lenvatinib in patients with advanced follicular cell-derived thyroid cancer.晚期滤泡细胞源性甲状腺癌患者一线乐伐替尼治疗的真实世界治疗结果及反应的临床病理和分子决定因素
BJC Rep. 2025 Jun 3;3(1):41. doi: 10.1038/s44276-025-00153-2.
6
[NIP7 upregulates the expression of ubiquitin-conjugating enzyme E2 C to promote tumor growth in anaplastic thyroid cancer].[NIP7上调泛素结合酶E2 C的表达以促进间变性甲状腺癌的肿瘤生长]
Zhejiang Da Xue Xue Bao Yi Xue Ban. 2025 May 25;54(3):372-381. doi: 10.3724/zdxbyxb-2024-0708.
7
NOVEL INSIGHTS IN ADVANCED THYROID CARCINOMA: FROM MECHANISMS TO TREATMENTS: Molecular insights into the origin, biology, and treatment of anaplastic thyroid carcinoma.晚期甲状腺癌的新见解:从机制到治疗:间变性甲状腺癌起源、生物学特性及治疗的分子见解
Eur Thyroid J. 2025 Jun 2;14(3). doi: 10.1530/ETJ-25-0057. Print 2025 Jun 1.
8
The Revolution of Targeted Therapies in Thyroid Cancer Treatment: Present and Future Promising Anti-Cancer Drugs.甲状腺癌治疗中靶向治疗的革命:当前及未来有前景的抗癌药物
Int J Mol Sci. 2025 Apr 12;26(8):3663. doi: 10.3390/ijms26083663.
9
() in Thyroid Tumors: Incidence, Significance, and Role as a Driver Gene and Secondary Alteration.甲状腺肿瘤中的():发生率、意义以及作为驱动基因和继发性改变的作用
Curr Oncol. 2025 Apr 11;32(4):224. doi: 10.3390/curroncol32040224.
10
Anaplastic thyroid cancer: Genetic roles, targeted therapy, and immunotherapy.间变性甲状腺癌:基因作用、靶向治疗及免疫治疗
Genes Dis. 2024 Aug 30;12(4):101403. doi: 10.1016/j.gendis.2024.101403. eCollection 2025 Jul.
基于免疫的 HPV 相关口咽癌分类及其对生物标志物驱动的治疗减量化的影响。
EBioMedicine. 2022 Dec;86:104373. doi: 10.1016/j.ebiom.2022.104373. Epub 2022 Nov 25.
4
Introduction and expression of PIK3CA in a papillary thyroid cancer BRAF cell line leads to a dedifferentiated aggressive phenotype.PIK3CA 在甲状腺癌 BRAF 细胞系中的引入和表达导致去分化的侵袭性表型。
J Otolaryngol Head Neck Surg. 2022 Feb 22;51(1):7. doi: 10.1186/s40463-022-00558-w.
5
Tumor molecular differences associated with outcome disparities of Black patients with head and neck cancer.与头颈部癌症黑人患者结局差异相关的肿瘤分子差异。
Head Neck. 2022 May;44(5):1124-1135. doi: 10.1002/hed.27007. Epub 2022 Feb 21.
6
Single-cell transcriptomic analysis of the tumor ecosystems underlying initiation and progression of papillary thyroid carcinoma.单细胞转录组分析甲状腺癌起始和进展中肿瘤生态系统。
Nat Commun. 2021 Oct 18;12(1):6058. doi: 10.1038/s41467-021-26343-3.
7
Hemicentin-1 is an essential extracellular matrix component of the dermal-epidermal and myotendinous junctions.半钙黏蛋白-1 是皮肤-表皮和肌-腱连接的必需细胞外基质成分。
Sci Rep. 2021 Sep 9;11(1):17926. doi: 10.1038/s41598-021-96824-4.
8
Characterizing dedifferentiation of thyroid cancer by integrated analysis.通过综合分析表征甲状腺癌的去分化
Sci Adv. 2021 Jul 28;7(31). doi: 10.1126/sciadv.abf3657. Print 2021 Jul.
9
Adjuvant Olaparib for Patients with - or -Mutated Breast Cancer.奥拉帕利辅助治疗 - 或 - 突变型乳腺癌患者。
N Engl J Med. 2021 Jun 24;384(25):2394-2405. doi: 10.1056/NEJMoa2105215. Epub 2021 Jun 3.
10
All HPV-negative head and neck cancers are not the same: Analysis of the TCGA dataset reveals that anatomical sites have distinct mutation, transcriptome, hypoxia, and tumor microenvironment profiles.所有 HPV 阴性的头颈部癌症都不相同:TCGA 数据集的分析表明,解剖部位具有不同的突变、转录组、缺氧和肿瘤微环境特征。
Oral Oncol. 2021 May;116:105260. doi: 10.1016/j.oraloncology.2021.105260. Epub 2021 Mar 13.